0001104659-23-076387.txt : 20230629 0001104659-23-076387.hdr.sgml : 20230629 20230629172132 ACCESSION NUMBER: 0001104659-23-076387 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230629 DATE AS OF CHANGE: 20230629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rubric Capital Management LP CENTRAL INDEX KEY: 0001687509 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 231058530 BUSINESS ADDRESS: STREET 1: 155 EAST 44TH ST, SUITE 1630 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2124181881 MAIL ADDRESS: STREET 1: 155 EAST 44TH ST, SUITE 1630 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosen David Efraim CENTRAL INDEX KEY: 0001898677 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 231058529 MAIL ADDRESS: STREET 1: 155 EAST 44TH ST., SUITE 1630 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-961-1900 MAIL ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 4 1 tm2320269-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-28 1 0000025743 TherapeuticsMD, Inc. TXMD 0001687509 Rubric Capital Management LP 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 1 0 1 1 See Remarks 0001898677 Rosen David Efraim 155 EAST 44TH ST., SUITE 1630 NEW YORK NY 10017 1 0 1 1 See Remarks 0 Common Stock, par value $0.001 per share ("Common Stock") 2023-06-28 4 A 0 312525 3.6797 A 2069716 I See footnote The Common Stock was purchased in connection with a Subscription Agreement entered into as of May 1, 2023 between the Issuer and Rubric Capital, as described in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 5, 2023. This Form 4 is filed by Rubric Capital Management LP ("Rubric Capital") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the "Rubric Vehicles"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital. The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. The Reporting Persons are directors by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Justin Roberts, a Partner at Rubric Capital, serves on the board of directors of the Issuer. Rubric Capital Management LP, By: /s/ Michael Nachmani, its Chief Operating Officer 2023-06-29 /s/ David Rosen 2023-06-29